Rep. John Shimkus, R-Ill. distinguished himself as a champion of the sector with the slew of FDA device reforms that he sponsored 21st Century Cures discussion draft released by House Energy and Commerce last month.
Shimkus' provisions, in particular, closely match AdvaMed's recently unveiled "Innovation Agenda" priorities, including measures to use a third-party quality system audit to replace a new 510(k) for minor modifications, to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?